We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$599M
AUM Growth
+$99.2M
(+20%)
Cap. Flow
+$49.8M
Cap. Flow
% of AUM
8.31%
Top 10 Holdings %
Top 10 Hldgs %
34.81%
Holding
710
New
83
Increased
162
Reduced
252
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$19.1M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$14.1M |
| 3 |
iShares MSCI Turkey ETF
TUR
|
+$14M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$10.8M |
| 5 |
iShares MSCI Thailand ETF
THD
|
+$9.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$16.7M |
| 2 |
Rogers Communications
RCI
|
+$6.28M |
| 3 |
TechnipFMC
FTI
|
+$5.75M |
| 4 |
PepsiCo
PEP
|
+$4.71M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 9.52% |
| 2 | Financials | 9.27% |
| 3 | Communication Services | 8.11% |
| 4 | Technology | 7.63% |
| 5 | Materials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Goldman Sachs
GS
$313B
| $107K | 0.02% |
478
+132
| +38% | +$31.5K |
|
327
Kinross Gold
KGC
$28.5B
| $106K | 0.02% |
+28,123
| New | +$106K |
|
328
PUT
Tesla
TSLA
$1.24T
| $105K | 0.02% |
300
| – | – |
|
329
Ecolab
ECL
$75.6B
| $104K | 0.02% |
734
-87
| -11% | -$12.5K |
|
|
SAGE
330
DELISTED
Sage Therapeutics
SAGE
| $103K | 0.02% |
662
| – | – |
|
331
Baytex Energy
BTE
$3.08B
| $101K | 0.02% |
30,772
| – | – |
|
332
Fastenal
FAST
$54B
| $98.5K | 0.02% |
8,048
| – | – |
|
|
FDC
333
DELISTED
First Data Corporation
FDC
| $98.3K | 0.02% |
+4,700
| New | +$87.1K |
|
334
Broadcom
AVGO
$1.82T
| $97.7K | 0.02% |
4,030
-54,360
| -93% | -$1.33M |
|
335
Autodesk
ADSK
$44.3B
| $96.9K | 0.02% |
736
-142
| -16% | -$18.8K |
|
336
First Horizon
FHN
$12.1B
| $96.8K | 0.02% |
5,314
| – | – |
|
337
Nucor
NUE
$56.4B
| $95.9K | 0.02% |
1,535
+77
| +5% | +$4.92K |
|
|
CLVS
338
DELISTED
Clovis Oncology, Inc.
CLVS
| $95.4K | 0.02% |
+2,100
| New | +$102K |
|
339
Target
TGT
$62.1B
| $95.1K | 0.02% |
1,240
-30,471
| -96% | -$2.24M |
|
|
CYBR
340
DELISTED
CyberArk
CYBR
| $94.4K | 0.02% |
+1,500
| New | +$87.6K |
|
341
Alaska Air
ALK
$5.15B
| $92.6K | 0.02% |
1,514
| – | – |
|
|
KERX
342
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $92.2K | 0.02% |
25,506
| – | – |
|
343
NexGen Energy
NXE
$6.05B
| $91.7K | 0.02% |
50,000
| – | – |
|
344
Xcel Energy
XEL
$51B
| $90.7K | 0.02% |
1,980
+76
| +4% | +$3.4K |
|
|
BPMC
345
DELISTED
Blueprint Medicines
BPMC
| $90.7K | 0.02% |
1,462
| – | – |
|
346
Morgan Stanley
MS
$337B
| $89.7K | 0.02% |
1,857
-332
| -15% | -$17.3K |
|
347
TAL Education Group
TAL
$5.71B
| $89.2K | 0.01% |
2,420
+2,419
| +241,900% | +$95.1K |
|
348
ProPetro Holding
PUMP
$1.45B
| $89.1K | 0.01% |
5,688
| – | – |
|
|
AAIC
349
DELISTED
Arlington Asset Investment Corp.
AAIC
| $88.8K | 0.01% |
8,558
+1,357
| +19% | +$15.1K |
|
350
Telecom Argentina
TEO
$5.89B
| $87.4K | 0.01% |
4,897
+611
| +14% | +$15.5K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2018 Portfolio in Review
As of Q2 2018, Exane Derivatives held 710 positions worth $599M, up 20% from $500M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Exane Derivatives deployed $49.8M of net new capital in Q2 2018, opening 83 new positions and adding to 162 existing holdings. Its largest new stake was UBS Group: 1,172,516 shares worth $18.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $16.7M trimmed.
- Exane Derivatives's largest Q2 2018 buy was UBS Group: 1,172,516 shares worth $18.1M.
- Exane Derivatives added most to VanEck Russia ETF in Q2 2018, an estimated $14.1M increase.
- Exane Derivatives's biggest Q2 2018 reduction was Freeport-McMoran, cutting an estimated $16.7M.
- Exane Derivatives fully exited Rogers Communications in Q2 2018, selling an estimated $6.28M.
- Exane Derivatives's ten largest holdings make up 35% of its $599M portfolio in Q2 2018.
- Exane Derivatives opened 83 new positions and closed 24 in Q2 2018.
- Exane Derivatives's portfolio value rose 20% quarter-over-quarter to $599M.
Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.